2-hydroxy-5-carbomethoxybenzyloxyamine: a new potent inhibitor of histidine decarboxylase.
D000284:Administration, Oral; D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors; D000596:Amino Acids; D000818:Animals; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D003067:Coenzymes / Q000037:antagonists & inhibitors; D006168:Guinea Pigs; D006639:Histidine; D006898:Hydroxylamines / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D007700:Kinetics; D007928:Lethal Dose 50; D008168:Lung / Q000201:enzymology; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology; D010226:Parabens; D010636:Phenols / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012867:Skin / Q000201:enzymology; D013270:Stomach / Q000201:enzymology; D013997:Time Factors
D000596:Amino Acids; D003067:Coenzymes; D006898:Hydroxylamines; D008996:Monoamine Oxidase Inhibitors; D010226:Parabens; D010636:Phenols; C007991:2-hydroxy-5-carbomethoxybenzyloxyamine; D006639:Histidine; D006631:Amine Oxidase (Copper-Containing); D002262:Carboxy-Lyases